Zhao Feng, Hu Yuan, Chong Chuanke, Lu Minghui, Chen Liping, Kan Weijuan, Chen Lei, Liu Hongwei
School of Pharmacy, Yantai University , Yantai , P.R. China .
Pharm Biol. 2014 Jul;52(7):797-803. doi: 10.3109/13880209.2013.869231. Epub 2014 Jan 6.
The in vitro and in vivo antitumor activities of ardisiphenol D, a natural product isolated from the roots of Ardisa brevicaulis Diels (Myrsinaceae), have been studied.
Previously, we have isolated and identified some chemical constituents from this plant. Furthermore, these compounds showed significant inhibition of the proliferation of human pancreatic PANC-1, human lung A549, human gastrointestinal carcinoma SGC 7901, human breast MCF-7, and human prostate PC-3 cancer cells. In the present paper, a major resorcinol derivative called ardisiphenol D was further studied for its antitumor mechanism.
MTT assay was used to detect the proliferation of A549 cancer cells. Apoptosis induced by ardisiphenol D was observed by Hoechst 33258 fluorescence staining. Caspase-3 enzyme activity was measured by a commercial caspase-3 enzyme activity detection kit. Protein expression of bax, bcl-2, and caspase-3 was tested by Western blots. In vivo antitumor activity of ardisiphenol D was evaluated by determination of A549 tumor growth in nude mice.
Ardisiphenol D significantly inhibited the proliferation of A549 cells with an IC50 of 0.997 μM with a 48 h treatment. Hoechst 33258 fluorescence staining results indicated the apoptosis of A549 cells induced by 3.125 μM of ardisiphenol D. About 0.39 and 0.78 μM of ardisiphenol D also potently increased the caspase-3 enzyme activity in 24 h. Furthermore, 0.39-3.125 μM of ardisiphenol D induced the activation of caspase-3 protein and the up-regulation of the ratio of bax/bcl-2 protein expression in A549 cells. After i.p. injection, ardisiphenol D (5 mg/kg) also strongly suppressed the A549 tumor growth in nude mice.
Ardisiphenol D induced apoptosis of A549 cells via activation of caspase-3 and up-regulation of the ratio of bax/bcl-2 protein expression. Ardisiphenol D also strongly suppressed the A549 tumor growth in nude mice and exerted antitumor activity in vivo.
从短茎紫金牛(紫金牛科)根中分离得到的天然产物矮地茶酚D的体外和体内抗肿瘤活性已得到研究。
此前,我们已从该植物中分离并鉴定了一些化学成分。此外,这些化合物对人胰腺PANC - 1、人肺A549、人胃肠道癌SGC 7901、人乳腺MCF - 7和人前列腺PC - 3癌细胞的增殖表现出显著抑制作用。在本文中,对一种名为矮地茶酚D的主要间苯二酚衍生物的抗肿瘤机制进行了进一步研究。
采用MTT法检测A549癌细胞的增殖。通过Hoechst 33258荧光染色观察矮地茶酚D诱导的细胞凋亡。使用商业半胱天冬酶 - 3酶活性检测试剂盒测定半胱天冬酶 - 3的酶活性。通过蛋白质免疫印迹法检测bax、bcl - 2和半胱天冬酶 - 3的蛋白表达。通过测定裸鼠体内A549肿瘤生长情况评估矮地茶酚D的体内抗肿瘤活性。
矮地茶酚D在48小时处理时显著抑制A549细胞增殖,IC50为0.997μM。Hoechst 33258荧光染色结果表明3.125μM矮地茶酚D诱导A549细胞凋亡。约0.39和0.78μM的矮地茶酚D在24小时时也能有效提高半胱天冬酶 - 3的酶活性。此外,0.39 - 3.125μM的矮地茶酚D诱导A549细胞中半胱天冬酶 - 3蛋白的激活以及bax/bcl - 2蛋白表达比值的上调。腹腔注射后,矮地茶酚D(5mg/kg)也强烈抑制裸鼠体内A549肿瘤的生长。
矮地茶酚D通过激活半胱天冬酶 - 3和上调bax/bcl - 2蛋白表达比值诱导A549细胞凋亡。矮地茶酚D还强烈抑制裸鼠体内A549肿瘤的生长并在体内发挥抗肿瘤活性。